TradingMenu expanded
Forge Markets Forge Pro Browse Companies
DataMenu expanded
Forge Data Private Market Index Forge Accuidity Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies
InsightsMenu expanded
All Insights Blog Glossary Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Updates Forge Investment Outlook Startup News Tech IPO Calendar for 2024
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Forge Pro
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
Forge Accuidity Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
Insights Menu expandedInsights
All Insights
Blog
Glossary
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Updates
Forge Investment Outlook
Startup News
Tech IPO Calendar for 2024
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Private Companies / Elucid Stock

Elucid Stock

www.elucid.com/Healthcare / Healthcare softwareFounded: 2009

Elucid is a diagnostic imaging company that uses artificial intelligence to improve vascular patient outcomes. With a mission to prevent cardiovascular disease and improve pathology accuracy, Elucid optimizes clinical precision with arterial plaque analysis. Elucid also features ct angiography, FFRct, plaque characterization, and non-coding transcripts. Elucid was founded by Andrew J. Buckler in 2013 and is headquartered in Boston, MA.

Buy or sell Elucid stockLearn more about Elucid IPO

Register To Buy and Sell Shares

For more details on financing and valuation for Elucid, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value

Powered by Forge Data

Access Elucid’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Elucid.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Register

Animation displayed is not current and securities are shown for illustrative purposes only.

Elucid investors also invested in these private companies

National Institutes of Health
IAG Capital Partners
Global Health Investment Fund
Elevage Medical Technologies
Aphelion Capital
Biovision Ventures
Philips Ventures
BlueStone Venture Partners
Bold Brain Ventures
Ice Age Gold
MedTex Ventures
Willamette Valley Capital
University of Michigan Endowment

Team

Management Team

Blake Richards
Chief Executive Officer
Andrew Miller
Chief Technology Officer & Senior Vice President Engineering
Scott Burger
Chief Commercial Officer
James Hamilton Ph.D
Co-Founder
Andrew Buckler
Co-Founder
Todd Villines
Chief Medical Officer

Board Members

Evan Melrose MD
Elevage Medical Technologies
Kelly Huang Ph.D
Elevage Medical Technologies

Frequently Asked Questions About Elucid’s Stock

plusminus
Can you buy Elucid’s stock?
Elucid is not publicly traded on NYSE or NASDAQ in the U.S. To buy Elucid’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
plusminus
Can you sell Elucid’s stock?
Yes, you can sell stock of a private company like Elucid. Forge can help you sell your Elucid stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
plusminus
What is Elucid’s stock price?
Elucid is a privately held company and therefore does not have a public stock price. However, you may access Elucid’s private market stock price with Forge Data.
plusminus
What is Elucid’s stock ticker symbol?
Elucid does not have an official ticker symbol because this company is not currently publicly traded.
plusminus
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Other companies like Elucid in the Healthcare software sector

Abridge

Sector
Healthcare / Healthcare software
Last Round Est. Valuation
$845.13MM

Hippocratic AI

Sector
Healthcare / Healthcare software
 
 

Ambience Healthcare

Sector
Healthcare / Healthcare software
 
 

Innovaccer

Sector
Healthcare / Healthcare software
Last Round Est. Valuation
$3.19B

Huma

Sector
Healthcare / Healthcare software
 
 

nference

Sector
Healthcare / Healthcare software
Last Round Est. Valuation
$858.38MM

TraceLink

Sector
Healthcare / Healthcare software
Last Round Est. Valuation
$657MM

Datavant

Sector
Healthcare / Healthcare software
 
 

Viz.ai

Sector
Healthcare / Healthcare software
Last Round Est. Valuation
$1.22B

News Highlights

Fierce Biotech 11/13/2023
Elucid collects $80M for AI-powered mapping of blocked arteries
The cardiovascular imaging company Elucid has made it clear they mean to deliver on their promise of artificial intelligence-powered exams to chart the insides of blocked arteries. And now they’ve raised $80 million to do so. Financially speaking, the startup has kept up its momentum since last year’s venture capital fundraising—with a $27 million series B in June 2022, which just about tripled its $8 million round from the year before. The most recent series C continues that trajectory, for a total of $121 million since Elucid’s founding.
Mobi Health News 11/10/2023
Elucid scores $80M for AI imaging analysis software and more digital health fundings
AI company Elucid had a series C funding round which raised $80 million.

Trending Companies

Frequently Asked Questions

Updated on: May 1, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.